CDNA CareDx Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CDNA

Price (delayed)

$9.76

Market cap

$528M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.68

Enterprise value

$480.69M

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Highlights
The debt has declined by 16% year-on-year and by 4.4% since the previous quarter
CareDx's net income has decreased by 22% YoY and by 8% from the previous quarter
CareDx's EPS has decreased by 19% YoY and by 7% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.caredx.com
Peers: TTOO AGIO NVTA ARDX

Key stats

What are the main financial stats of CDNA
Market
Shares outstanding
54.1M
Market cap
$528M
Enterprise value
$480.69M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.34
Price to sales (P/S)
1.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.62
Earnings
Revenue
$297.14M
EBIT
-$100.95M
EBITDA
-$81.67M
Free cash flow
-$13.75M
Per share
EPS
-$1.68
Free cash flow per share
-$0.25
Book value per share
$7.28
Revenue per share
$5.48
TBVPS
$7.65
Balance sheet
Total assets
$501.18M
Total liabilities
$107.05M
Debt
$29.25M
Equity
$394.13M
Working capital
$272.49M
Liquidity
Debt to equity
0.07
Current ratio
4.75
Quick ratio
4.41
Net debt/EBITDA
0.58
Margins
EBITDA margin
-27.5%
Gross margin
64.4%
Net margin
-30.5%
Operating margin
-33.6%
Efficiency
Return on assets
-17.3%
Return on equity
-21.9%
Return on invested capital
-32.3%
Return on capital employed
-23.6%
Return on sales
-34%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDNA stock price

How has the CareDx stock price performed over time
Intraday
0%
1 week
-0.71%
1 month
95.2%
1 year
-19.07%
YTD
-14.46%
QTD
39.43%

Financial performance

How have CareDx's revenue and profit performed over time
Revenue
$297.14M
Gross profit
$191.26M
Operating income
-$99.85M
Net income
-$90.52M
Gross margin
64.4%
Net margin
-30.5%
CareDx's operating margin has decreased by 45% YoY and by 17% from the previous quarter
The operating income has declined by 36% year-on-year and by 13% since the previous quarter
The net margin has declined by 30% year-on-year and by 13% since the previous quarter
CareDx's net income has decreased by 22% YoY and by 8% from the previous quarter

Growth

What is CareDx's growth rate over time

Valuation

What is CareDx stock price valuation
P/E
N/A
P/B
1.34
P/S
1.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.62
CareDx's EPS has decreased by 19% YoY and by 7% from the previous quarter
The stock's price to book (P/B) is 81% less than its 5-year quarterly average of 6.9 but 12% more than its last 4 quarters average of 1.2
The equity has decreased by 10% YoY and by 2.7% from the previous quarter
The price to sales (P/S) is 80% less than the 5-year quarterly average of 8.8 but 19% more than the last 4 quarters average of 1.5
The revenue has decreased by 7% YoY and by 3.9% QoQ

Efficiency

How efficient is CareDx business performance
CareDx's ROS has decreased by 40% YoY and by 14% from the previous quarter
The ROE has contracted by 33% YoY and by 11% from the previous quarter
CDNA's return on assets is down by 28% year-on-year and by 9% since the previous quarter
The ROIC fell by 14% QoQ but it rose by 7% YoY

Dividends

What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDNA.

Financial health

How did CareDx financials performed over time
CDNA's current ratio is down by 14% year-on-year
The company's quick ratio fell by 14% YoY and by 2% QoQ
The debt is 93% smaller than the equity
The debt has declined by 16% year-on-year and by 4.4% since the previous quarter
CareDx's debt to equity has decreased by 13% QoQ and by 13% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.